Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

The Oncology Institute, Inc. TOI

Set alert

Price alert · TOI

All alert types
5.13 USD 0.00 0.00%

At close · Aug 3

5.28 +0.15 +2.92%

After hours · Aug 3, 4:00 PM ET

Bid
5.37 × 3
Ask
5.38 × 1
4.87 Day range 5.15
0.125 52-week range 2.50
YTD
+44.10%
1 year
+129.02%
Open
4.94
Prev close
5.13
Mkt cap
15.42M
Vol
1.21M
Avg vol
1.67M
EPS
-0.77
P/E
0.00
Div yield
0.00%
More statistics
Low
4.87
High
5.15
Forward P/E
-1.28
Beta
0.62
Short ratio
3.38
Inst. own
47.59%
Dividend
0.00
Ex-div date
50-d avg
0.24794
200-d avg
0.5979
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for TOI has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

2.28 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -6.6×
FY 2018: 69.3×FY 2019: -155×FY 2020: -45.0×FY 2021: -60.9×FY 2022: 1833×FY 2023: -2.2×FY 2024: -0.4×FY 2025: -6.6×
FY 2018 5y median -2.2× FY 2025
P/S 6.5×
FY 2018: 5.5×FY 2019: 4.0×FY 2020: 3.4×FY 2021: 3.2×FY 2022: 0.5×FY 2023: 0.5×FY 2024: 0.1×FY 2025: 6.5×
FY 2018 5y median 0.5× FY 2025
P/B -209×
FY 2018: 0.0×FY 2019: 14.8×FY 2020: 22.7×FY 2021: 6.2×FY 2022: 1.0×FY 2023: 2.6×FY 2024: 6.5×FY 2025: -209×
FY 2018 5y median 2.6× FY 2025
P/FCF -118×
FY 2018: 126×FY 2019: 259×FY 2020: -931×FY 2021: -18.1×FY 2022: -1.8×FY 2023: -3.7×FY 2024: -0.8×FY 2025: -118×
FY 2018 5y median -3.7× FY 2025
EV/EBITDA -79.0×
FY 2018: 0.0×FY 2019: 2028×FY 2020: -57.1×FY 2021: -12.6×FY 2022: -3.2×FY 2023: -4.4×FY 2024: -1.9×FY 2025: -79.0×
FY 2018 5y median -4.4× FY 2025
EV/Sales 6.7×
FY 2018: 0.0×FY 2019: 4.0×FY 2020: 3.4×FY 2021: 2.6×FY 2022: 0.8×FY 2023: 0.7×FY 2024: 0.2×FY 2025: 6.7×
FY 2018 5y median 0.8× FY 2025
FCF Yield -0.8%
FY 2018: 0.8%FY 2019: 0.4%FY 2020: -0.1%FY 2021: -5.5%FY 2022: -56.0%FY 2023: -27.2%FY 2024: -130.8%FY 2025: -0.8%
FY 2018 5y median -27.2% FY 2025

Profitability

Gross Margin 15.2%
FY 2018: 23.2%FY 2019: 19.3%FY 2020: 19.7%FY 2021: 20.1%FY 2022: 20.6%FY 2023: 18.4%FY 2024: 13.7%FY 2025: 15.2%
FY 2018 5y median 18.4% FY 2025
Operating Margin -7.2%
FY 2018: 4.2%FY 2019: -1.7%FY 2020: -4.4%FY 2021: -22.6%FY 2022: -32.5%FY 2023: -23.8%FY 2024: -15.3%FY 2025: -7.2%
FY 2018 5y median -22.6% FY 2025
Net Margin -12.1%
FY 2018: 3.5%FY 2019: -2.6%FY 2020: -7.6%FY 2021: -5.4%FY 2022: 0.1%FY 2023: -25.6%FY 2024: -16.4%FY 2025: -12.1%
FY 2018 5y median -12.1% FY 2025
ROE 385.5%
FY 2018: 0.0%FY 2019: -9.5%FY 2020: -51.0%FY 2021: -10.5%FY 2022: 0.1%FY 2023: -145.7%FY 2024: -1801.7%FY 2025: 385.5%
FY 2018 5y median -10.5% FY 2025
ROIC -35.7%
FY 2018: 0.0%FY 2019: -5.8%FY 2020: -18.7%FY 2021: -24.9%FY 2022: 57.6%FY 2023: -42.6%FY 2024: -47.2%FY 2025: -35.7%
FY 2018 5y median -35.7% FY 2025
ROA -36.8%
FY 2018: 0.0%FY 2019: -6.8%FY 2020: -21.8%FY 2021: -5.4%FY 2022: 0.1%FY 2023: -39.7%FY 2024: -37.4%FY 2025: -36.8%
FY 2018 5y median -36.8% FY 2025

Growth (YoY)

Revenue 27.8%
FY 2018: 0.0%FY 2019: 37.3%FY 2020: 20.7%FY 2021: 8.3%FY 2022: 24.4%FY 2023: 28.4%FY 2024: 21.3%FY 2025: 27.8%
FY 2018 FY 2025
Operating Income 40.0%
FY 2018: 0.0%FY 2019: -155.2%FY 2020: -209.9%FY 2021: -459.5%FY 2022: -78.7%FY 2023: 6.0%FY 2024: 21.9%FY 2025: 40.0%
FY 2018 FY 2025
EPS (diluted) 23.9%
FY 2018: 0.0%FY 2019: -144.6%FY 2020: -284.6%FY 2021: 33.3%FY 2022: -31.2%FY 2023: -338.1%FY 2024: 22.8%FY 2025: 23.9%
FY 2018 FY 2025
Free Cash Flow 8.4%
FY 2018: 0.0%FY 2019: -51.3%FY 2020: -128.5%FY 2021: -5108.0%FY 2022: -88.3%FY 2023: 39.2%FY 2024: 25.8%FY 2025: 8.4%
FY 2018 FY 2025

Financial Health

Current Ratio 1.6×
FY 2018: 0.0×FY 2019: 1.6×FY 2020: 1.0×FY 2021: 5.2×FY 2022: 4.4×FY 2023: 4.1×FY 2024: 2.2×FY 2025: 1.6×
FY 2018 5y median 4.1× FY 2025
Quick Ratio 1.4×
FY 2018: 0.0×FY 2019: 1.3×FY 2020: 0.9×FY 2021: 5.0×FY 2022: 4.1×FY 2023: 3.7×FY 2024: 2.0×FY 2025: 1.4×
FY 2018 5y median 3.7× FY 2025
Debt / Equity -6.6×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.4×FY 2021: 0.0×FY 2022: 0.9×FY 2023: 2.1×FY 2024: 34.3×FY 2025: -6.6×
FY 2018 5y median 0.9× FY 2025
Net Debt / EBITDA -1.6×
FY 2018: 0.0×FY 2019: -8.0×FY 2020: -0.5×FY 2021: 2.7×FY 2022: -1.4×FY 2023: -1.6×FY 2024: -1.4×FY 2025: -1.6×
FY 2018 5y median -1.4× FY 2025
Interest Coverage -3.2×
FY 2018: 3009×FY 2019: -784×FY 2020: -23.6×FY 2021: -143×FY 2022: -20.1×FY 2023: -11.4×FY 2024: -8.0×FY 2025: -3.2×
FY 2018 5y median -11.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 1.3%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 207.7%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31